Identification of fibroblasts as a major site of albumin catabolism in peripheral tissues

J. L. Strobel, S. G. Cady, T. K. Borg, L. Terracio, J. W. Baynes, S. R. Thorpe

Research output: Contribution to journalArticle

Abstract

Rat serum albumin has been labeled with dilactitol-125I-tyramine, (125I-DLT) a radioactive tracer which remains entrapped within lysosomes following cellular uptake and degradation of the carrier protein. Similar kinetics of clearance from the rat circulation were observed for albumin labeled conventionally with 125I or 125I-DLT-albumin, both proteins having circulating half-lives of ~2.2 days. In contrast, the recovery of whole body radioactivity had half-lives of ~2.2 and 5.1 days, respectively, for the two protein preparations, indicating substantial retention of degradation products derived from catabolism of 125I-DLT-albumin. Measurement of total and acid-soluble radioactivity in tissues 2 or 4 days after injection of 125I-DLT-albumin revealed that skin and muscle accounted for the largest fraction (50-60%) of degradation products in the body. Fibroblasts were identified by autoradiography as the major cell type containing radioactive degradation products in skin and muscle. Fibroblasts were isolated from skin by collagenase digestion, followed by density gradient centrifugation. The amount of acid-soluble radioactivity recovered in these cells was in excellent agreement with that predicted based on acid precipitation of solubilized whole skin preparations. These studies demonstrate for the first time that fibroblasts are a major cell type involved in the degradation of albumin in vivo.

Original languageEnglish (US)
Pages (from-to)7989-7994
Number of pages6
JournalJournal of Biological Chemistry
Volume261
Issue number17
StatePublished - 1986

Fingerprint

Fibroblasts
Albumins
Tissue
Skin
Radioactivity
Degradation
Acids
Muscle
Rats
Radioactive Tracers
Muscles
Tyramine
Density Gradient Centrifugation
Centrifugation
Collagenases
Lysosomes
Autoradiography
Serum Albumin
Digestion
Carrier Proteins

ASJC Scopus subject areas

  • Biochemistry

Cite this

Strobel, J. L., Cady, S. G., Borg, T. K., Terracio, L., Baynes, J. W., & Thorpe, S. R. (1986). Identification of fibroblasts as a major site of albumin catabolism in peripheral tissues. Journal of Biological Chemistry, 261(17), 7989-7994.

Identification of fibroblasts as a major site of albumin catabolism in peripheral tissues. / Strobel, J. L.; Cady, S. G.; Borg, T. K.; Terracio, L.; Baynes, J. W.; Thorpe, S. R.

In: Journal of Biological Chemistry, Vol. 261, No. 17, 1986, p. 7989-7994.

Research output: Contribution to journalArticle

Strobel, JL, Cady, SG, Borg, TK, Terracio, L, Baynes, JW & Thorpe, SR 1986, 'Identification of fibroblasts as a major site of albumin catabolism in peripheral tissues', Journal of Biological Chemistry, vol. 261, no. 17, pp. 7989-7994.
Strobel, J. L. ; Cady, S. G. ; Borg, T. K. ; Terracio, L. ; Baynes, J. W. ; Thorpe, S. R. / Identification of fibroblasts as a major site of albumin catabolism in peripheral tissues. In: Journal of Biological Chemistry. 1986 ; Vol. 261, No. 17. pp. 7989-7994.
@article{e63c01c7a7e34c9eacb6d1e15bb0f5ad,
title = "Identification of fibroblasts as a major site of albumin catabolism in peripheral tissues",
abstract = "Rat serum albumin has been labeled with dilactitol-125I-tyramine, (125I-DLT) a radioactive tracer which remains entrapped within lysosomes following cellular uptake and degradation of the carrier protein. Similar kinetics of clearance from the rat circulation were observed for albumin labeled conventionally with 125I or 125I-DLT-albumin, both proteins having circulating half-lives of ~2.2 days. In contrast, the recovery of whole body radioactivity had half-lives of ~2.2 and 5.1 days, respectively, for the two protein preparations, indicating substantial retention of degradation products derived from catabolism of 125I-DLT-albumin. Measurement of total and acid-soluble radioactivity in tissues 2 or 4 days after injection of 125I-DLT-albumin revealed that skin and muscle accounted for the largest fraction (50-60{\%}) of degradation products in the body. Fibroblasts were identified by autoradiography as the major cell type containing radioactive degradation products in skin and muscle. Fibroblasts were isolated from skin by collagenase digestion, followed by density gradient centrifugation. The amount of acid-soluble radioactivity recovered in these cells was in excellent agreement with that predicted based on acid precipitation of solubilized whole skin preparations. These studies demonstrate for the first time that fibroblasts are a major cell type involved in the degradation of albumin in vivo.",
author = "Strobel, {J. L.} and Cady, {S. G.} and Borg, {T. K.} and L. Terracio and Baynes, {J. W.} and Thorpe, {S. R.}",
year = "1986",
language = "English (US)",
volume = "261",
pages = "7989--7994",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "17",

}

TY - JOUR

T1 - Identification of fibroblasts as a major site of albumin catabolism in peripheral tissues

AU - Strobel, J. L.

AU - Cady, S. G.

AU - Borg, T. K.

AU - Terracio, L.

AU - Baynes, J. W.

AU - Thorpe, S. R.

PY - 1986

Y1 - 1986

N2 - Rat serum albumin has been labeled with dilactitol-125I-tyramine, (125I-DLT) a radioactive tracer which remains entrapped within lysosomes following cellular uptake and degradation of the carrier protein. Similar kinetics of clearance from the rat circulation were observed for albumin labeled conventionally with 125I or 125I-DLT-albumin, both proteins having circulating half-lives of ~2.2 days. In contrast, the recovery of whole body radioactivity had half-lives of ~2.2 and 5.1 days, respectively, for the two protein preparations, indicating substantial retention of degradation products derived from catabolism of 125I-DLT-albumin. Measurement of total and acid-soluble radioactivity in tissues 2 or 4 days after injection of 125I-DLT-albumin revealed that skin and muscle accounted for the largest fraction (50-60%) of degradation products in the body. Fibroblasts were identified by autoradiography as the major cell type containing radioactive degradation products in skin and muscle. Fibroblasts were isolated from skin by collagenase digestion, followed by density gradient centrifugation. The amount of acid-soluble radioactivity recovered in these cells was in excellent agreement with that predicted based on acid precipitation of solubilized whole skin preparations. These studies demonstrate for the first time that fibroblasts are a major cell type involved in the degradation of albumin in vivo.

AB - Rat serum albumin has been labeled with dilactitol-125I-tyramine, (125I-DLT) a radioactive tracer which remains entrapped within lysosomes following cellular uptake and degradation of the carrier protein. Similar kinetics of clearance from the rat circulation were observed for albumin labeled conventionally with 125I or 125I-DLT-albumin, both proteins having circulating half-lives of ~2.2 days. In contrast, the recovery of whole body radioactivity had half-lives of ~2.2 and 5.1 days, respectively, for the two protein preparations, indicating substantial retention of degradation products derived from catabolism of 125I-DLT-albumin. Measurement of total and acid-soluble radioactivity in tissues 2 or 4 days after injection of 125I-DLT-albumin revealed that skin and muscle accounted for the largest fraction (50-60%) of degradation products in the body. Fibroblasts were identified by autoradiography as the major cell type containing radioactive degradation products in skin and muscle. Fibroblasts were isolated from skin by collagenase digestion, followed by density gradient centrifugation. The amount of acid-soluble radioactivity recovered in these cells was in excellent agreement with that predicted based on acid precipitation of solubilized whole skin preparations. These studies demonstrate for the first time that fibroblasts are a major cell type involved in the degradation of albumin in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0022979943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022979943&partnerID=8YFLogxK

M3 - Article

VL - 261

SP - 7989

EP - 7994

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 17

ER -